Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents

AIM: The efficacy and safety of insulin degludec (IDeg), a new basal insulin with an ultra-long duration of action, was compared to sitagliptin (Sita) in a 26-week, open-label trial. METHODS: Insulin-naïve subjects with type 2 diabetes [n = 458, age: 56 years, diabetes duration: 7.7 years, glycosyla...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Philis-Tsimikas, A, Del Prato, S, Satman, I, Bhargava, A, Dharmalingam, M, Skjøth, T V, Rasmussen, S, Garber, A J
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2013
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3799217/
https://ncbi.nlm.nih.gov/pubmed/23577643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados